Previous 10 |
home / stock / gnhay / gnhay news
Vifor Pharma AG (GNHAF) Q2 2021 Earnings Conference Call August 5, 2021, 8:00 am ET Company Participants Colin Bond - CFO Klaus Jensen - CMO Conference Call Participants Christian Glennie - Stifel James Gordon - JPMorgan Rosie Turner - Barclays Paul Verbraeken - Research Partners Barbora Blah...
The following slide deck was published by Vifor Pharma AG in conjunction with their 2021 Q2 earnings call. For further details see: Vifor Pharma AG 2021 Q2 - Results - Earnings Call Presentation
Vifor Pharma AG (GNHAF) Q4 2020 Results Earnings Conference Call March 3, 2021, 08:00 AM ET Company Participants Colin Bond - Chief Financial Officer Stefan Schulze - Chief Executive Officer Conference Call Participants Daniel Wendorff - Commerzbank Christian Glennie - Stifel Rosie Turner - B...
The following slide deck was published by Vifor Pharma AG in conjunction with their 2020 Q4 earnings call. For further details see: Vifor Pharma AG 2020 Q4 - Results - Earnings Call Presentation
Vifor Pharma AG (GNHAY): FY Non-GAAP EPS of CHF4.99.Revenue of CHF1.71B (-1.2% Y/Y)Press Release For further details see: Vifor Pharma AG reports FY results
The following slide deck was published by Vifor Pharma AG in conjunction with this event. For further details see: Vifor Pharma (GNHAF) Investor Presentation - Slideshow
The Vifor Pharma Group ( OTC:GNHAY ) and Akebia Therapeutics (NASDAQ: AKBA ) have amended the terms of their licence agreement to sell vadadustat to Fresenius Medical Care North America dialysis clinics in U.S., subject to FDA approval. More news on: Vifor Pharma AG, Akebia Therapeutics,...
News, Short Squeeze, Breakout and More Instantly...
Vifor Pharma AG ADR Company Name:
GNHAY Stock Symbol:
OTCMKTS Market:
CSL BEHRING AG PUBLISHES OFFER PROSPECTUS ON PUBLIC TENDER OFFER FOR ALL PUBLICLY HELD SHARES OF VIFOR PHARMA LTD. Ad hoc release pursuant to Art. 53 LR, Switzerland PR Newswire MELBOURNE, Australia and ST. GALLEN, Switzerland , Jan. 18, 2022 /PRNewswire/...